Company intelligence / Profile preview

Shandong Haiyu Biological

Shandong, China

Ownership: Private
Development stage: Other

Overview

The company is a leading Chinese manufacturer of chondroitin sulfate and related biologic ingredients, focusing on veterinary and pet health applications, particularly for joint health. Its products are widely used in the global pet supplement market, especially for osteoarthritis and joint function in animals.

Therapeutic areas: OtherRheumatology
Modalities: BiologicSmall molecule
Industry: Veterinary

Beyond the preview

Go deeper on Shandong Haiyu Biological.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shandong Haiyu Biological.

Explore the full profile